Nice work buddy, I will try the same when I get bored. But in the meantime, did you know that Kim Kardashian is showing off her new curves?
I just want to keep everyone up to date that Kim Kardashian is showing off her new curves. Thank you for your attention. This is like watching paint dry.
With all the manipulation and doubling downs, now up to their necks with 77 mil shares. Shares are running dry. Oh boy, it appears that the longs are frustrated but more so, I think the shorts are panicking and don't know how to get out of this mess.
We will see tomorrow. My guess is 3 years, then it becomes mnkd 100% Basically, I think Sanofi is just providing advertisement, salesman, study costs but Mankind still is responsible for manufacturing costs. Retaining manufacturing responsibility is smart because if the sales is a blockbuster they can easily retain manufacturing facilities and go alone 3 years down the road.
3 years for $1 bill is damn good! and Sanofi gets 65% of profit? Sanofi will profit greatly from it. For break even in those 3 years, all mnkd has to do is profit about $600 mil/year x3 years. 65% of 600 mil is about 400 mil per year x 3= $1.2 bil Thus, Sanofi has to think that mnkd will at least profit about 500-600 mil each year for the first 3 years for them to break even with this deal.
the sentiment is that they are looking for an entry to cover. We already know that Al Mann hates shorts. The incidence where Adam Feurestein was at the Adcom screaming at the FDA to reject Afrezza was enough to have Dr. Mann's blood in a boil.
I have a small position, fishing for that moment where they start the covering and ride along the coattail.
can't make sense of the short interest rising despite 30% drop, and company is on the brink of buyout, partner, and having a drug that could revoluntionalize the biggest drug market. Very strange.... indeed.
so, regardless of what the share price is; they just continue to short because eventually the price is determined by the offering price anyways? Just a thought.
is that statement legally bound? any lawyer in the house?
this may not have anything to do with Afrezza but with 75 mil shares shorted currently, the rocket will take off straight up. There is no time for a trajectory here; the panic and mayhem among shorts will cause them to slaughter one another.
"WE have buyout offer at $7 billion but we are not taking that offer yet and still looking for better offers and partnership" The stocks shoots up to $20 share and trading haults.
I would rather roast my testicles on fire than to sell at this level. You are ridiculous!
OK, I will call Roberta at IR to verify if such manipulation exists. Then I will report you and Alfred Mann for stock manipulation. LOL
Et tu brutus?! selling calls options higher than 15 price target? Did I say too much?
the price of the trades dictates where this is going, it justifies my explanation. I am not overzealous like many longs. Of course, I would love to see $50/sh as you people pump but I am not a pumper, I am realist. I will be happy with $12-15/sh buyout which seems to justify the lack of short coverage.
are you trying to convince investors into buying your 15 and higher calls options? Did I say too much? LOL
unlike you, I don't try to sucker investors into buying my options which will all expire worthless in a couple of months. Did I say too much there?
you have a better explanation for what has transpired? Look at all the facts around you and come up with one explanation that best suits all your facts. Buyout at $4-6 billion, not enough to scare short coverage.
Looking at the trading patern and silence of the company, with the volume of shorts unchanged since FDA approval suggest that this is a buyout. Unfortunately, the selling price isn't that much. My guess is somewhere around $4-6 bil which would put the pps around 10-15. Some of the shorts knew this already but they don't know the exact determined price; that is the reason why the shorts have not covered. Why cover when it is only a couple of bucks off (or it could be $4 bil, which would put pps at $10-11). If they start covering for expected buyout price, let's say $15/sh, they could generate a massive short coverage rally that could go to $20. The problem is that at $20, Mankind may back out of the buyout, and instead Alfred Mann may decide to sell his shares at $20 instead of buyout at $15.
What mnkd is doing now is remaining in silence, sad to say but I have to agree with some of the shorts theory here, that Alfred Mann, may be doing some insiders tradings. A. Mann may be accumulating cheaper shares in order to make profits. But I am going to hold on to all my shares because I don't think they would sell Afrezza and Technosphere for less than $4 bil. 20% profit is all I am hoping for (buyout at $4-6 bil)